Clinical Overview
Doxycycline remains a first-line option for tick-borne disease (Lyme disease, ehrlichiosis, Rocky Mountain spotted fever, anaplasmosis), as well as leptospirosis, mycoplasma, and other bacterial infections in canine and feline patients.
The Course-Completion Problem
Doxycycline protocols typically run several weeks, and course non-completion is a common contributor to treatment failure and resistance concerns — particularly in patients that resist oral dosing or in multi-pet households where consistent administration is difficult.
Compounded Formats That Support Adherence
PetScript Pharmacy compounds doxycycline hyclate into chicken-flavored, scored split tablets that allow for flexible, weight-adjusted dosing across a full treatment course, as well as oral suspension, transdermal gel, and powder formats for patients that won't tolerate tablets.
Partnering for Better Outcomes
When a multi-week antibiotic course is on the line, formulation choice can be the difference between a completed course and a callback. Contact our clinical compounding team to discuss strength, flavor, and delivery options that fit your antimicrobial protocols.
Learn more: visit our Doxycycline Compounding for Tick-Borne and Bacterial Disease Protocols page, or reach our clinical compounding team directly at info@petscript.net / 866-784-6915.
